BR0003972A - New compound isolated from the extract of the fungus guignardia sp. and its use in drug compositions - Google Patents
New compound isolated from the extract of the fungus guignardia sp. and its use in drug compositionsInfo
- Publication number
- BR0003972A BR0003972A BR0003972-1A BR0003972A BR0003972A BR 0003972 A BR0003972 A BR 0003972A BR 0003972 A BR0003972 A BR 0003972A BR 0003972 A BR0003972 A BR 0003972A
- Authority
- BR
- Brazil
- Prior art keywords
- extract
- new compound
- compound isolated
- drug compositions
- guignardia
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"NOVO COMPOSTO ISOLADO DO EXTRATO DO FUNGO GUIGNARDIA SP. E SEU USO EM COMPOSIçõES MEDICAMENTOSAS". A presente invenção apresenta uma nova molécula contendo um anel dioxolanona, ou um sal do mesmo, possuindo a seguinte fórmula: A invenção apresenta ainda uma composição farmacêutica para ser usada no tratamento de infecções microbianas, preferencialmente no tratamento de doenças causadas por fungos e bactérias."NEW COMPOUND ISOLATED FROM THE FUNGUS EXTRACT GUIGNARDIA SP. AND ITS USE IN MEDICINAL COMPOSITIONS". The present invention features a new molecule containing a dioxolanone ring, or a salt thereof, having the following formula: The invention also features a pharmaceutical composition to be used in the treatment of microbial infections, preferably in the treatment of diseases caused by fungi and bacteria.
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR0003972-1A BR0003972A (en) | 2000-09-01 | 2000-09-01 | New compound isolated from the extract of the fungus guignardia sp. and its use in drug compositions |
US09/918,717 US6544524B2 (en) | 2000-09-01 | 2001-08-01 | Ethyl acetate extract from guignardia used to treat an individual infected by fungi or bacteria |
EP01959996A EP1318824B1 (en) | 2000-09-01 | 2001-08-29 | Extracts from the fungus guignardia sp., their uses in pharmaceutical compositions, new isolate compound from the extract of the fungus guignardia sp. and its use in pharmaceutical compositions |
AU2001281613A AU2001281613A1 (en) | 2000-09-01 | 2001-08-29 | Extracts from the fungus guignardia sp., their uses in pharmaceutical compositions, new isolate compound from the extract of the fungus guignardia sp. and its use in pharmaceutical compositions |
DE60109465T DE60109465D1 (en) | 2000-09-01 | 2001-08-29 | EXTRACTS OF THE MUSHROOM GUIGNARDIA SP., THEIR USE IN PHARMACEUTICAL COMPOUNDS; NEW ISOLATED CONNECTION FROM GUIGNARDIA SP. MUSHROOM EXTRACTS AND THEIR USE IN PHARMACEUTICAL PREPARATIONS |
AT01959996T ATE290875T1 (en) | 2000-09-01 | 2001-08-29 | EXTRACTS OF THE MUSHROOM GUIGNARDIA SP., THE USE THEREOF IN PHARMACEUTICAL COMPOUNDS; NEWLY INSULATED CONNECTION MADE OF GUIGNARDIA SP. MUSHROOM EXTRACTS AND THEIR USE IN PHARMACEUTICAL PREPARATIONS |
PCT/BR2001/000110 WO2002017937A1 (en) | 2000-09-01 | 2001-08-29 | Extracts from the fungus guignardia sp., their uses in pharmaceutical compositions, new isolate compound from the extract of the fungus guignardia sp. and its use in pharmaceutical compositions |
IT2001MI001837A ITMI20011837A1 (en) | 2000-09-01 | 2001-08-31 | EXTRACTS FROM FUNGUS GUIGNARDIA SP., THEIR USE IN PHARMACEUTICAL COMPOSITIONS, NEW COMPOUND ISOLATED FROM THE FUNGUS GUIGNARDIA EXTRACT |
US10/369,761 US20030165532A1 (en) | 2000-09-01 | 2003-02-21 | Extracts from the fungus Guignardia sp., their uses in pharmaceutical compositions, new isolate compound from the extract of the fungus Gignardia sp. and its use in pharmaceutical compositions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR0003972-1A BR0003972A (en) | 2000-09-01 | 2000-09-01 | New compound isolated from the extract of the fungus guignardia sp. and its use in drug compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0003972A true BR0003972A (en) | 2002-04-16 |
Family
ID=3945141
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0003972-1A BR0003972A (en) | 2000-09-01 | 2000-09-01 | New compound isolated from the extract of the fungus guignardia sp. and its use in drug compositions |
Country Status (1)
Country | Link |
---|---|
BR (1) | BR0003972A (en) |
-
2000
- 2000-09-01 BR BR0003972-1A patent/BR0003972A/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0001899D0 (en) | New compounds | |
BR0214343A (en) | 11 - Beta - Hydroxy Steroid Dehydrogenase Inhibitors Type 1 | |
MXPA04004837A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1. | |
MXPA04004842A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1. | |
BR0012674A (en) | Preserved pharmaceutical formulations | |
SE0300010D0 (en) | Novel Compounds | |
IL171977A (en) | Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same | |
IL127965A0 (en) | Pentafluorobenzenesulfonamide derivatives analogs thereof and pharmaceutical compositions containing the same | |
BR0000003A (en) | Azalides and methods of preparing them | |
NO20063277L (en) | Pharmaceutical composition of vinflunine intended for parenteral administration, preparation and use thereof | |
HUP0102515A2 (en) | Cyclopeptides, process for their preparation, pharmaceutical compositions comprising thereof and their use | |
RS44204A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
DE60024857D1 (en) | NEW CONNECTIONS | |
BRPI0409818A (en) | compounds, pharmaceutical compositions, method for the treatment or prophylaxis of diseases, and uses of compounds and one or more compounds in combination with other pharmacologically active compounds | |
PT1414467E (en) | TOP TREATMENT OF MASTALGIA | |
BRPI0409878A (en) | compounds, pharmaceutical compositions, method for the treatment or prophylaxis of diseases, and uses of compounds and one or more compounds in combination with other pharmacologically active compounds | |
BRPI0409881A (en) | compounds, pharmaceutical compositions, method for the treatment or prophylaxis of diseases, and uses of compounds and one or more compounds in combination with other pharmacologically active compounds | |
BR0006301A (en) | Antibacterial and prokinetic macrolides | |
BR0309878A (en) | Heterotricyclyl-6-alkylidene penenes as beta-lactamase inhibitors | |
RS44304A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
BRPI0413684A (en) | compounds, pharmaceutical composition and methods of preparation, treatment of microbial infection and extermination of microorganism and uses | |
GEP20032970B (en) | Pharmaceutical Compositions of Tizoxanide and Nitazoxanide | |
DE50113974D1 (en) | COMBINATION PREPARATIONS OF 3-N-FORMYLHYDROXYLAMINOPROPYLPHOSPHONIC ACID DERIVATIVES OR 3-N-ACETYLHYDROXYLAMINOPROPYLPHOSPHONIC ACID DERIVATIVES WITH SPECIAL PHARMACEUTICAL ACTIVE SUBSTANCES | |
BR0003972A (en) | New compound isolated from the extract of the fungus guignardia sp. and its use in drug compositions | |
DE602004017586D1 (en) | MEDICAL COMPOSITION FOR THE TREATMENT OF INFECTIONS WITH DRUG-RESISTANT STAPHYLOCOCCUS AUREUS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 7AANUIDADE. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008. |